Davis Thomas Andrew 4
4 · Celldex Therapeutics, Inc. · Filed Sep 13, 2012
Insider Transaction Report
Form 4
Davis Thomas Andrew
Sr. VP & CMO
Transactions
- Award
Incentive Stock Option
2012-09-12+115,000→ 115,000 totalExercise: $5.69From: 2013-09-12Exp: 2022-09-12→ Common Stock (115,000 underlying)
Footnotes (1)
- [F1]25% vest on September 12, 2013 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.